CW July 2001

category image Volume 10
Issue Number 7
July 2001
ISSN 10593802

Iressa, An Effective Inhibitor of Tamoxifen-Resistant Breast Cancer Growth

The epidermal growth factor receptor- (EGFR) selective tyrosine kinase inhibitor Iressa (ZD1839) may be an active treatment in tamoxifen-resistant breast cancer, early research suggests.
Go to Previous Page
Go to Next Page

Source & Additional Reading

J. M. Gee, Tenovus Centre for Cancer Research, Cardiff, UK.
Robert C. Shepard, MD, associate professor of medicine, University of Virginia Cancer Center, Charlottesville, VA.
Christophe Louvet, MD, Hôpital St-Antoine, Paris, France.

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly.  Click here for details.

Download Complete Issue CW July 2001

Purchase Downloadable Full-text PDF of Complete Issue: $10.00

Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us

Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA
phone: 518-456-0784; fax: 518-452-4955; email: info@adeninepress.com
copyright © Adeninepress, All rights reserved.




Re-initialize IP-based Login

Mountain Media ecommerce solutions Ecommerce Solutions by Mountain Media